Your session is about to expire
← Back to Search
Behavioral Intervention
Personality-Based Therapy for Borderline Personality Disorder
N/A
Recruiting
Led By Shannon Sauer-Zavala, PhD
Research Sponsored by Shannon E. Sauer-Zavala
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up weekly up to 14 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial assesses the effectiveness of a treatment module for borderline personality disorder over a 6 week period and 4 week follow-up.
Who is the study for?
This trial is for English-speaking individuals diagnosed with Borderline Personality Disorder. It's not suitable for those who have other psychological conditions needing different treatments, are currently in psychotherapy, have substance use disorders, or whose medication use isn't stable.
What is being tested?
The study tests a new therapy specifically designed for personality changes in people with Borderline Personality Disorder. Participants will first be observed without treatment and then receive six weekly sessions of the therapy to see its effects.
What are the potential side effects?
Since this trial involves therapy sessions rather than medication, typical medical side effects aren't expected. However, discussing emotional topics may cause temporary discomfort or distress.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ weekly up to 14 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~weekly up to 14 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in clinician-rated borderline personality disorder symptoms
Change in patient-reported borderline personality disorder symptoms
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Group I: Personality-based treatment 4 week baselineExperimental Treatment1 Intervention
Participants will receive treatment tailored to 1 of 3 personality dimensions after a 4 week baseline assessment
Group II: Personality-based treatment 2 week baselineExperimental Treatment1 Intervention
Participants will receive treatment tailored to 1 of 3 personality dimensions after a 2 week baseline assessment
Find a Location
Who is running the clinical trial?
National Institute of Mental Health (NIMH)NIH
2,933 Previous Clinical Trials
2,746,008 Total Patients Enrolled
13 Trials studying Borderline Personality Disorder
2,033 Patients Enrolled for Borderline Personality Disorder
American Psychological FoundationOTHER
18 Previous Clinical Trials
1,943 Total Patients Enrolled
Shannon E. Sauer-ZavalaLead Sponsor
4 Previous Clinical Trials
366 Total Patients Enrolled
1 Trials studying Borderline Personality Disorder
100 Patients Enrolled for Borderline Personality Disorder
Shannon Sauer-Zavala, PhDPrincipal InvestigatorUniversity of Kentucky
2 Previous Clinical Trials
136 Total Patients Enrolled
1 Trials studying Borderline Personality Disorder
8 Patients Enrolled for Borderline Personality Disorder